DD vs PRLD · P/E 127, rev $12.39B vs rev $6.5M
Dupont De Nemours Inc (DD) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the DD and PRLD stock pages for the full models.
Not investment advice.